Artson (522134)

FairStock Score: 19/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 79.45% shows strong top-line momentum
• Latest quarter sales of ₹32 Cr indicate a scaling business, though currently unprofitable
• ROCE of 24.57% suggests some operational return on capital, if the metric is reliable

Concerns

• Net loss of ₹12 Cr on ₹32 Cr quarterly sales implies roughly a 37% negative margin
• Profit growth of -291.54% and P/E of 0.00 mean no earnings support for the price
• Book value, debt/equity and promoter holding are N/A, leaving financial health opaque
• Piotroski F-Score of 4/9, FairStock Score of 19/100, and zero dividend point to high risk

AI Analysis

Let me be blunt: Artson fails my first test—it makes no money. The P/E is 0.00 because there are no earnings. Last quarter it booked ₹32 Cr revenue and lost ₹12 Cr, a 37% negative margin. Graham would call this speculation, not investment: you are paying ₹155.50 for a share of a company whose profit growth is -291.54%. The 79.45% sales growth looks exciting, but many small industrial firms grow revenue while burning cash; growth without earnings is not value creation. The balance sheet is a black box: book value and debt/equity are N/A. I cannot judge safety of principal without knowing net worth or leverage. The 586.97% ROE sounds extraordinary, but with book value missing it is likely an artifact of a thin equity base, not a moat. ROCE of 24.57% is the only positive signal, yet it sits awkwardly against a net loss. No dividend means no compensation for waiting. The Piotroski F-Score of 4/9 and FairStock Score of 19/100 reinforce caution. At ₹584 Cr market cap, the market values Artson at roughly 4.6 times annualized latest-quarter sales of ₹128 Cr. For a loss-making company, that is no margin of safety. The 52-week range ₹125.30–₹216.85 shows volatility; the stock is closer to the lower end, but cheap can get cheaper. Missing promoter holding data also prevents me from seeing if insiders own shares. Artson may one day turn around—sales are rising—but I prefer facts. Here there is high risk, poor fundamentals, and no earnings anchor. I will pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer